Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients

Digestive Diseases and Sciences

Volumn 52, Issue 7, 2007, Pages 1673-1677

  Kusano, Motoyasu ^a   Shimoyama, Yasuyuki ^a   Kawamura, Osamu ^b   Maeda, Masaki ^b   Kuribayashi, Shikou ^b   Nagoshi, Atsuto ^b   Zai, Hiroaki ^b   Moki, Fumitaka ^b   Horikoshi, Tsutomu ^b   Toki, Munetoshi ^b   Sugimoto, Sayaka ^b   Mori, Masatomo ^b  

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acid related dyspepsia; Frequency scale for symptoms of GERD; Gastroesophageal reflux disease; Proton pump inhibitor

Indexed keywords

ACID; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ACIDITY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPEPSIA; EROSION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; SYMPTOM;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON-TRANSLOCATING ATPASES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 34249899657     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9674-3     Document Type: Article

References (19)

1. Kusano M, Shimoyama Y, Sugimoto S, et al. (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39:888-891
2. Dupuy HJ (1984) The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, et al. (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq, New York, pp 170-183
3. Svedlund J, Sjodin I, Dotevall G (1988) GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134
4. Ware JE, Sherbourne CD (1992) The MOS 36-item short form health survey (SF-36). Med Care 30:473-481
5. Jones RH, Baxter G (1997) Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 11:541-546
6. Quigley EMM (2004) Review article: gastric emptying in functional gastrointestinal disorders. Aliment Pharmacol Ther 20(Suppl 7):56-60
7. Armstrong D, Bennett JR, Blum AL, et al. (1996) The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 111:85-92
8. Hoshihara Y (1998) Reflux esophagitis. In: Nagasako K, Fujimori T, Hoshihara Y, Tabuchi M (eds) Atlas of gastroenterologic endoscopy by high-resolution video-endoscope. Igaku-Shoin, Tokyo, p 32
9. Oda K, Iwakiri R, Hara M, et al. (2005) Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor. Dig Dis Sci 50:1921-1926
10. Shi G, Bruley dV, Scarpignato C, Le RM, Galmiche JP (1995) Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 37:457-464
11. Hobson AR, Khan RW, Sarkar S, Furlong PL, Aziz Q (2004) Development of esophageal hypersensitivity following experimental duodenal acidification. Am J Gastroenterol 99:813-820
12. Lee KJ, Kim JH, Cho SW (2006) Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification. J Gastroenterol Hepatol 21:515-520
13. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J (2001) Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121:526-535
14. Herculano JRL, Troncon LE, Aprile LR, et al. (2004) Diminished retention of food in the proximal stomach correlates with increased acidic reflux in patients with gastroesophageal reflux disease and dyspeptic symptoms. Dig Dis Sci 49:750-756
15. Maddern GJ, Jamieson GG, Myers JC, Collins PJ (1991) Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease. Gut 32:470-474
16. Berstad A (1998) Today's therapy of functional gastrointestinal disorders-Does it help? Eur J Surg 583(Suppl):92-97
17. Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G (2004) Features of gastroesophageal reflux disease in women. Am J Gastroenterol 99:1442-1447
18. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C (2006) A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 354:832-840
19. Vigneri S, Termini R, Leandro G, et al. (1995) A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 333:1106-1110